IMMX Company Profile and Key Details

Q: Who are the executives of IMMX?

Dr. Graham Ross FFPM, M.D.Chief Medical Officer & Head of Clinical Devel.Dr. Ilya Rachman M.B.A., M.D., MBA, Ph.D.Co-Founder, Chief Executive Officer & ChairmanMr. Gabriel Morris B.A.Chief Financial Officer & DirectorMr. Sean Senn J.D., M.B.A., M.Sc., MBA, MScCo-FounderDr. Vladimir P. Torchilin D.Sc., MSE, Ph.D.Scientific Co-FounderMr. Ben H. Lyon J.D.Executive Vice President & Gen. CounselMr. Nandan Oza B.S.Head of Chemistry, Manufacturing & Control

NASDAQ : IMMX

Immix Biopharma

$8.80

-0.61-6.48%

At Close 4:00 PM

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Immix Biopharma, Inc. (IMMX) stock declined over -6.48%, trading at $8.80 on NASDAQ, down from the previous close of $9.41. The stock opened at $9.24, fluctuating between $8.78 and $9.46 in the recent session.

Stock Snapshot

9.41

Prev. Close

478.74M

Market Cap

8.78

Day Low

-9.67

P/E Ratio

-0.91

EPS (TTM)

-0.57

Cash Flow per Share

9.24

Open

54.4M

Number of Shares

9.455

Day High

67.26%

Free Float in %

0.82

Book Value

994.45K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Jul 23, 2026	9.23	9.46	8.78	8.80	994.45K
Jul 22, 2026	9.78	9.79	9.27	9.41	1.81M
Jul 21, 2026	8.91	9.69	8.83	9.57	2.48M
Jul 20, 2026	10.00	10.05	8.67	8.80	3.91M
Jul 17, 2026	9.80	10.58	9.69	10.25	1.06M
Jul 16, 2026	10.46	10.47	9.81	10.06	1.5M
Jul 15, 2026	10.66	10.88	10.11	10.53	980.74K
Jul 14, 2026	10.58	11.08	10.49	10.68	1.19M
Jul 13, 2026	11.19	11.19	10.36	10.52	1.25M
Jul 10, 2026	11.09	11.24	10.44	11.11	1.62M
Jul 09, 2026	10.99	11.49	10.73	11.09	1.45M
Jul 08, 2026	11.65	12.00	10.71	11.00	2.43M
Jul 07, 2026	10.59	12.14	10.05	12.02	4.24M
Jul 06, 2026	10.29	11.12	10.29	10.45	1.32M
Jul 02, 2026	9.87	10.46	9.74	10.34	2.07M
Jul 01, 2026	10.15	10.29	9.60	9.83	2.05M
Jun 30, 2026	10.48	10.79	10.27	10.31	2.39M
Jun 29, 2026	10.00	10.54	9.74	10.49	1.85M
Jun 26, 2026	9.66	10.30	9.60	9.98	7.14M
Jun 25, 2026	9.96	10.25	9.64	9.72	1.35M

Contact Details

Los Angeles, CA 90064

United States

https://www.immixbio.com 310 651 8041

About Company

Immix Biopharma, Inc. is a clinical-stage biotechnology firm dedicated to creating a range of tissue-specific therapies. Operating in both the United States and Australia, their primary focus areas are oncology (cancer) and inflammatory diseases. Their product pipeline includes IMX-110, which is currently undergoing Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and various solid tumors. They are also developing IMX-111, a targeted biologic agent for colorectal cancers, and IMX-120, another tissue-specific biologic designed to address ulcerative colitis and severe Crohn's disease. In a strategic move, the company has forged a clinical collaboration and supply agreement with BeiGene Ltd. This partnership aims to conduct a Phase 1b combination clinical trial, evaluating IMX-110 in conjunction with BeiGene's anti-PD-1 drug, Tislelizumab, for solid tumor indications. Founded in 2012, Immix Biopharma maintains its headquarters in Los Angeles, California.

Stock Peers

ARGX

72.88+8.56%

argenx SE$924.60 REGN

0.73+0.11%

Regeneron Pharmaceuticals, Inc.$651.91 MDGL

5.7+1.06%

Madrigal Pharmaceuticals, Inc.$543.35 UTHR

2.46+0.47%

United Therapeutics Corporation$529.53 VRTX

0.52+0.11%

Vertex Pharmaceuticals Incorporated$473.09 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 KRYS

-9.3-2.76%

Krystal Biotech, Inc.$327.50 ONC

6.84+2.14%

BeOne Medicines AG$326.77 PRAX

10.3+3.30%

Praxis Precision Medicines, Inc.$322.40 LGND

-2.11-0.69%

Ligand Pharmaceuticals Incorporated$302.15

Frequently Asked Questions

What is the current Immix Biopharma, Inc. (IMMX) stock price?

Immix Biopharma, Inc. (NASDAQ: IMMX) stock price is $8.80 in the last trading session. During the trading session, IMMX stock reached the peak price of $9.46 while $8.78 was the lowest point it dropped to. The percentage change in IMMX stock occurred in the recent session was -6.48% while the dollar amount for the price change in IMMX stock was - $0.61.

IMMX's industry and sector of operation?

The NASDAQ listed IMMX is part of Biotechnology industry that operates in the broader Healthcare sector. Immix Biopharma, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of IMMX?

Dr. Graham Ross FFPM, M.D.
Chief Medical Officer & Head of Clinical Devel.
Dr. Ilya Rachman M.B.A., M.D., MBA, Ph.D.
Co-Founder, Chief Executive Officer & Chairman
Mr. Gabriel Morris B.A.
Chief Financial Officer & Director
Mr. Sean Senn J.D., M.B.A., M.Sc., MBA, MSc
Co-Founder
Dr. Vladimir P. Torchilin D.Sc., MSE, Ph.D.
Scientific Co-Founder
Mr. Ben H. Lyon J.D.
Executive Vice President & Gen. Counsel
Mr. Nandan Oza B.S.
Head of Chemistry, Manufacturing & Control

How IMMX did perform over past 52-week?

IMMX's closing price is 353.61% higher than its 52-week low of $1.94 where as its distance from 52-week high of $12.14 is -27.51%.

How many employees does IMMX have?

Number of IMMX employees currently stands at 21.

Link for IMMX official website?

Official Website of IMMX is: https://www.immixbio.com

How do I contact IMMX?

IMMX could be contacted at phone 310 651 8041 and can also be accessed through its website. IMMX operates from 11400 West Olympic Boulevard, Los Angeles, CA 90064, United States.

How many shares of IMMX are traded daily?

IMMX stock volume for the day was 994.45K shares. The average number of IMMX shares traded daily for last 3 months was 1.65M.

What is the market cap of IMMX currently?

The market value of IMMX currently stands at $478.74M with its latest stock price at $8.80 and 54.4M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	21
Beta	0.09
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	21
Beta	0.09
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

IMMX Company Profile and Key Details

Immix Biopharma

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Shareholding & Insider Activity

Dividend & Fair Value

Earnings & Analyst Outlook

Financial & Profitability Overview

Quarterly Financial Highlights

Company Overview

Valuation Metrics

Price Forecast & Outlook

Key Takeaways